从B细胞淋巴瘤-2抑制剂开发看国内外药企专利布局的异同
The similarities and differences in patent distribution of domestic and foreign pharmaceutical companies from the perspective of B-cell lymphoma-2 inhibitors
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |